Cerebras Systems Inc

Cerebras Systems Inc (CBRS) Stock Analysis

$179.080

-7.289 (-4.07%)At close

Loading chart…
High
183.970
Open
183.830
VWAP
179.98
Vol
5.37M
Mkt Cap
Low
176.890
Amount
965.81M
EV/EBITDA, TTM
-4.94

Cerebras Systems Inc. is an artificial intelligence (AI) infrastructure company that designs and manufactures an AI compute platform comprised of proprietary systems and software. The Company's products include inference Cloud, Training Cloud, CS-3 system, AI supercomputer, Wafer Scale Engine and model development. The Company's pioneering Wafer-Scale Engine (WSE), a chip encompassing an entire silicon wafer, was specifically designed to enable higher performance and speeds than GPUs for the computational demands of inference, Generative AI (GenAI), and other AI applications. It offers deployment services to assist customers with data preparation, model architecture design, training management, inference optimization, and, in select cases, ongoing system operations and management. It also offers a subscription service providing access to an ongoing stream of software updates and upgrades for purchasers of its hardware.

AI analysis of Cerebras Systems Inc (CBRS)

hold

Cerebras Systems Inc. (CBRS) is currently trading at $179.08, which is significantly below the analyst price target of $300 from Mizuho, indicating potential upside. However, the stock has a low RSI of 30.475, suggesting it is oversold, but the recent 5-day change of -8.69% raises concerns about short-term momentum. The company's gross margin has dropped to 14.19% in Q2 2026, which is a significant decline from previous quarters, indicating potential profitability issues. The main risk is the substantial net income loss of $450.53 million in Q2 2026, which could impact investor confidence and stock performance in the near term.

Valuation Metrics

The current forward P/E ratio for Cerebras Systems Inc (CBRS) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

Overvalued
5Y Average EV/EBITDA
-152.02
Current EV/EBITDA
-4.94
Overvalued
-57.81
Undervalued
-246.22

Forward P/S

Fair
5Y Average P/S
16.02
Current P/S
15.02
Overvalued
17.74
Undervalued
14.31

Whales holding CBRS

A

ARK Investment Management LLC

+ HoldingCBRS

+4.40%

3M Return

S

Suvretta Capital Management, LLC

+ HoldingCBRS

+2.26%

3M Return

H

Harvard Management Company, Inc.

+ HoldingCBRS

+2.22%

3M Return

V

Verition Fund Management LLC

+ HoldingCBRS

+2.10%

3M Return

J

Jain Global LLC

+ HoldingCBRS

+1.40%

3M Return

B

BW Gestao de Investimentos Ltda.

+ HoldingCBRS

-0.51%

3M Return

Events Timeline

2026-08-20 (ET)

09:00:00

Cerebras Partners with Callosum to Launch AI Compute

2026-08-18 (ET)

10:30:00

Cerebras Systems Stock Price Declines

2026-08-17 (ET)

12:30:00

Cerebras Systems Stock Price Rises

10:30:00

Cerebras Systems Stock Price Rises

2026-08-13 (ET)

16:30:00

Major Averages Rise as Oil Prices Fall

News

CBRS FAQ — answered by Alphio AI

Cerebras Systems Inc. is an artificial intelligence (AI) infrastructure company that designs and manufactures an AI compute platform comprised of proprietary systems and software. The Company's products include inference Cloud, Training Cloud, CS-3 system, AI supercomputer, Wafer Scale Engine and model development. The Company's pioneering Wafer-Scale Engine (WSE), a chip encompassing an entire silicon wafer, was specifically designed to enable higher performance and speeds than GPUs for the computational demands of inference, Generative AI (GenAI), and other AI applications. It offers deployment services to assist customers with data preparation, model architecture design, training management, inference optimization, and, in select cases, ongoing system operations and management. It also offers a subscription service providing access to an ongoing stream of software updates and upgrades for purchasers of its hardware. It operates in the Technology sector.

Cerebras Systems Inc. (CBRS) is currently trading at $179.08, which is significantly below the analyst price target of $300 from Mizuho, indicating potential upside. However, the stock has a low RSI of 30.475, suggesting it is oversold, but the recent 5-day change of -8.69% raises concerns about short-term momentum. The company's gross margin has dropped to 14.19% in Q2 2026, which is a significant decline from previous quarters, indicating potential profitability issues. The main risk is the substantial net income loss of $450.53 million in Q2 2026, which could impact investor confidence and stock performance in the near term.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started